Matches in Nanopublications for { ?s ?p "[In all, 171 patients with breast cancer who had HER2 FISH that had increased mean CEP17 copy numbers (> 2.6) were selected for additional chromosome 17 studies that used probes for Smith-Magenis syndrome (SMS), retinoic acid receptor alpha (RARA), and tumor protein p53 (TP53) genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP548348.RARdo9FuWuyhS-z5QjDr2PJEepEOEDmSHvbTniXQhNazQ130_assertion description "[In all, 171 patients with breast cancer who had HER2 FISH that had increased mean CEP17 copy numbers (> 2.6) were selected for additional chromosome 17 studies that used probes for Smith-Magenis syndrome (SMS), retinoic acid receptor alpha (RARA), and tumor protein p53 (TP53) genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548348.RARdo9FuWuyhS-z5QjDr2PJEepEOEDmSHvbTniXQhNazQ130_provenance.
- NP881994.RAiVT8-nQPHklBZ0-CLKo5sf49ClLFQowGDrIO5UpirvA130_assertion description "[In all, 171 patients with breast cancer who had HER2 FISH that had increased mean CEP17 copy numbers (> 2.6) were selected for additional chromosome 17 studies that used probes for Smith-Magenis syndrome (SMS), retinoic acid receptor alpha (RARA), and tumor protein p53 (TP53) genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881994.RAiVT8-nQPHklBZ0-CLKo5sf49ClLFQowGDrIO5UpirvA130_provenance.